| 2024-06-23 | +1050.3% | news | Zacks Investment Research | Tectonic Therapeutic, Inc. (TECX) - Zacks Investment Research |
| 2025-01-30 | +110.5% | news | Seeking Alpha | Tectonic Therapeutic: Stock Spikes On Heart Failure Data -- Why I See Further Upside |
| 2025-01-30 | +110.5% | news | Seeking Alpha | Tectonic jumps on positive data from early-stage trial for lead asset |
| 2024-06-20 | -91.1% | M&A | Seeking Alpha | Tectonic, AVROBIO complete merger, announce $130.7M private placement |
| 2025-01-28 | -37.9% | news | Seeking Alpha | Eli Lilly trial update on kidney drug hurts Tectonic |
| 2026-03-06 | +22.5% | news | Seeking Alpha | Tectonic Therapeutic, Inc. (TECX) Presents at TD Cowen 46th Annual Health Care Conference Transcript |
| 2025-02-05 | -12.0% | news | Seeking Alpha | Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data |
| 2026-02-25 | +11.8% | news | MarketBeat | Tectonic Therapeutic Spotlights TX2100 in HHT as First-in-Human Phase 1 Dosing Begins |
| 2024-08-22 | +11.7% | news | Seeking Alpha | Tectonic draws bullish view at Wells Fargo on lead asset |
| 2025-02-03 | -11.3% | news | Seeking Alpha | Tectonic announces ~$185M capital raise |
| 2025-02-03 | -11.3% | news | GlobeNewswire | Tectonic Announces $185 Million Private Placement - GlobeNewswire |
| 2025-04-23 | +11.1% | news | Seeking Alpha | Tectonic Therapeutic: A Buy On Massive Opportunity Of TX45 In PH HFpEF |
| 2026-02-10 | -11.1% | news | MT Newswires | Top Premarket Decliners |
| 2026-02-11 | +9.5% | news | GlobeNewswire | Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026 |
| 2024-11-20 | +9.3% | analyst | Seeking Alpha | Tectonic started at outperform by Raymond James, TX45 cited |
| 2024-01-30 | -6.3% | news | Seeking Alpha | Avrobio to buy 100% equity interests of Tectonic Therapeutic |
| 2026-02-14 | -5.5% | news | Simply Wall St. | Daniel Lochner Bought 70% More Shares In Tectonic Therapeutic |
| 2026-03-19 | -5.1% | news | CNW Group | TD Asset Management Inc. Announces TD ETF Distributions |
| 2026-03-02 | +4.9% | news | GlobeNewswire | Tectonic Therapeutic to Participate in March Investor Conferences |
| 2025-05-13 | -4.7% | news | Zacks Investment Research | Should I buy Tectonic Therapeutic, Inc. (TECX) - Zacks Investment Research |
| 2025-08-07 | -4.4% | earnings | Seeking Alpha | Tectonic Therapeutic GAAP EPS of -$1.07 |
| 2025-05-08 | +3.6% | earnings | Seeking Alpha | Tectonic Therapeutic GAAP EPS of -$0.93 beats by $0.16 |
| 2024-06-03 | -3.6% | executive | Seeking Alpha | Tectonic Therapeutic appoints Daniel Lochner as CFO |
| 2025-11-10 | -3.6% | news | simplywall.st | Companies Like Tectonic Therapeutic (NASDAQ:TECX) Are In A Position To Invest In Growth - simplywall.st |
| 2024-06-26 | +3.0% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2025-03-20 | -3.0% | earnings | Seeking Alpha | AVROBIO GAAP EPS of -$0.84 beats by $0.55 |
| 2026-02-26 | +2.5% | news | GlobeNewswire | Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights |
| 2026-02-26 | +2.5% | earnings | Seeking Alpha | Tectonic Therapeutic GAAP EPS of -$1.03 beats by $0.08 |
| 2025-09-03 | +2.3% | analyst | Seeking Alpha | Tectonic Therapeutic a new outperform at Oppenheimer on heart drug asset |
| 2024-07-30 | -2.3% | legal | Seeking Alpha | Tectonic gets FDA okay to begin clinical testing for lead drug TX45 |
| 2026-04-03 | -2.2% | news | Cổng thông tin điện tử tỉnh Tây Ninh | TECX Decline Deepens: Next Support in Sight - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2025-11-07 | -2.2% | earnings | Seeking Alpha | Tectonic Therapeutic GAAP EPS of -$1.02 beats by $0.05 |
| 2026-04-16 | -2.1% | news | Seeking Alpha | Tectonic Therapeutic: A $1B+ Opportunity Hinges On Upcoming Phase 2 |
| 2025-06-30 | +1.4% | news | Seeking Alpha | Tectonic Therapeutic joins Russell 3000 index |
| 2024-07-19 | +1.4% | news | Seeking Alpha | Tectonic Therapeutic files to sell 2.97M shares of common stock for holders |
| 2024-10-20 | -1.2% | news | Seeking Alpha | Tectonic Therapeutic: Interesting CV Disease Drug Developer |
| 2024-11-08 | +1.1% | earnings | Seeking Alpha | AVROBIO GAAP EPS of -$1.20 |
| 2025-10-31 | -1.0% | news | Seeking Alpha | Tectonic Therapeutic, Inc. (TECX) Discusses Positive Topline Results From Phase Ib Part B Trial of TX45 in PH-HFrEF Patients Transcript |
| 2025-01-05 | -0.8% | news | Seeking Alpha | Tectonic Therapeutic: Protein Engineering Platform For GPCRs |
| 2024-08-05 | +0.6% | M&A | Seeking Alpha | Tectonic Therapeutic: Analyzing Its Post-Merger Valuation And Prospects |
| 2025-10-29 | -0.5% | news | Seeking Alpha | Tectonic surges on phase 1b data for pulmonary hypertension asset |
| 2025-11-17 | +0.4% | news | Seeking Alpha | Tectonic: Strong Buy On Positive Phase 1b TX45 Data And 2026 Inflection Point |
| 2024-12-30 | -0.3% | news | Seeking Alpha | Tectonic Therapeutic: Waiting For A Pullback |
| 2026-04-23 | -0.2% | executive | GlobeNewswire | Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors |
| 2026-04-23 | -0.2% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | TECX (Tectonic Therapeutic Inc.) posts narrower Q4 2025 loss than analyst estimates, but shares dip nearly one percent today. - Recovery Stocks - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-23 | -0.2% | news | Stock Titan | Morgan Stanley biotech banker Jessica Chutter joins Tectonic board - Stock Titan |
| 2026-04-23 | -0.2% | news | Stock Titan | Veteran banker Jessica Chutter joins Tectonic (NASDAQ: TECX) board - Stock Titan |
| 2026-02-23 | +0.2% | executive | GlobeNewswire | Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board |
| 2026-04-24 | — | news | Stock Titan | Tectonic Therapeutic (TECX) details 2026 virtual meeting, board elections and say-on-pay - Stock Titan |
| 2026-04-24 | — | news | The Globe and Mail | Tectonic Therapeutic Adds Veteran Banker to Board - The Globe and Mail |